Antiretroviral therapy use among HIV-infected men who have sex with men attending a sexually transmitted diseases clinic

Journal of Acquired Immune Deficiency Syndromes

Volumn 55, Issue 4, 2010, Pages 524-527

  Dombrowski, Julia C ^a,b   Kerani, Roxanne P ^a,b   Stekler, Joanne D ^a,b   Menza, Timothy ^c   Golden, Matthew R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

antiretroviral therapy; delivery of health care; highly active; HIV infections drug therapy prevention and control transmission; homosexuality; male statistics and numerical data; sexual behavior

Indexed keywords

VIRUS RNA;

ACCURACY; ADULT; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE TRANSMISSION; HEALTH CENTER; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PRIORITY JOURNAL; SELF REPORT; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

ADULT; AMBULATORY CARE FACILITIES; ANTI-RETROVIRAL AGENTS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HOSPITALS, PUBLIC; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RISK FACTORS; UNSAFE SEX; WASHINGTON;

EID: 78650253134     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181f7e2d7     Document Type: Article

References (17)

1. Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23:1397-1404.
2. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092-2098.
3. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010;5:e11068.
4. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48-57.
5. Lima VD, Johnston K, Hogg RS, et al. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis. 2008;198:59-67.
6. Montaner JS, Lima VD, Barrios R, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010;376. [E-pub ahead of print].
7. Sullivan PS, Hamouda O, Delpech V, et al. Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996-2005. Ann Epidemiol. 2009;19:423-431.
8. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009; 373:1352-1363.
9. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009; 360:1815-1826.
10. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Washington, D.C. Department of Health and Human Services; December 1, 2009:1-161. Available at http://www.aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL.pdf. Accessed April 12, 2010.
11. Golden MR, Stekler J, Hughes JP, et al. HIV serosorting in men who have sex with men: is it safe? J Acquir Immune Defic Syndr. 2008;49:212-218.
12. Fraser C, Hollingsworth TD, Chapman R, et al. Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci USA. 2007;104:17441-17446.
13. Golden MR, Wood RW, Buskin SE, et al. Ongoing risk behavior among persons with HIV in medical care. AIDS Behav. 2007;11:726-735.
14. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157:940-943.
15. Golden MR, Hogben M, Potterat JJ, et al. HIV partner notification in the United States: a national survey of program coverage and outcomes. Sex Transm Dis. 2004;31:709-712.
16. Cassels S, Menza TW, Goodreau SM, et al. HIV serosorting as a harm reduction strategy: evidence from Seattle, Washington. AIDS. 2009;23: 2497-2506.
17. Golden MR, Goodreau S, Hughes J, et al. Estimation of the proportion of new HIV cases among men who have sex with men transmitted from persons in different stages of HIV infection, diagnosis, and treatment. Paper# 1001. Presented at: 17th Conference on Retroviruses and Opportunistic Infections; 2010; San Francisco.